Autres langues Hangzhou Tigermed Consulting Co., Ltd

Actions

300347

CNE100001KV8

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 25/04/2024			Varia. 5j.	Varia. 1 janv.
53,01 ^CNY	+0,78 %		+2,47 %	-3,57 %

25/04	Les bénéfices de Hangzhou Tigermed Consulting en baisse de 59% au 1er trimestre	MT
25/04	Hangzhou Tigermed Consulting Co, Ltd publie ses résultats pour le premier trimestre clos le 30 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	25/04
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	25/04
Borse Cina : chiudono miste, male Shanghai -0,7%, bene Hong Kong +1,92%	23/04
Tigermed Consulting's Profit, Revenue Climb in 2023	29/03
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024	28/03
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes	21/03
China Healthcare Stocks Rally on Hopes for Government Support	14/03
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares	14/03
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%	07/02
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.	06/02
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.	06/02
Hangzhou Tigermed Consulting's Profit Up 19% in Q3	27/10/23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Tigermed Reports 2023 Interim Results	28/08/23
Tigermed Consulting's Profit Jumps 16.5% in H1	28/08/23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Tigermed Officially Opens International Headquarters in Hong Kong	17/08/23
Bioclub announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd	07/08/23
Hangzhou Tigermed Consulting Co., Ltd. Announces Final Profit Distribution Plan Implementation (A Shares) for 2022, Payable on 07 July 2023	04/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hangzhou Tigermed Consulting Co., Ltd

Actions

300347

CNE100001KV8

Autres langues

Filtres